Posterior Ischemic Optic Neuropathy Because of Hematologic Malignancy

Affiliations

¹ Department of Laboratory Medicine and Pathology (AUP), Mayo Clinic, Rochester, Minnesota; Department of Radiology (USP), Swedish Medical Center, Seattle, Washington; and Departments of Ophthalmology and Neurology (EFM), University of Washington, Seattle, Washington.

Ankush U Patel et al. J Neuroophthalmol. 2024.

. 2024 Mar 1;44(1):e52-e54.

doi: 10.1097/WNO.0000000000001763. Epub 2022 Dec 21.

¹ Department of Laboratory Medicine and Pathology (AUP), Mayo Clinic, Rochester, Minnesota; Department of Radiology (USP), Swedish Medical Center, Seattle, Washington; and Departments of Ophthalmology and Neurology (EFM), University of Washington, Seattle, Washington.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

1. Myers KA, Nikolic A, Romanchuk K, Weis E, Brundler M-A, Lafay-Cousin L, Costello F. Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency. Neurooncol Pract. 2017;4:60–66.
1. Quddus A, Lawlor M, Siddiqui A, Holmes P, Plant GT. Using diffusion-weighted magnetic resonance imaging to confirm a diagnosis of posterior ischaemic optic neuropathy: two case reports and literature review. Neuroophthalmology. 2015;39:161–165.
1. Cheung M, Fang B, Lee R. Optic neuropathy as the first sign of central nervous system relapse in acute myeloid leukaemia: MRI findings and its diagnostic challenge. BMJ Case Rep. 2019;12:e228125.
1. Sudhakar P, Rodriguez FR, Trobe JD. MRI restricted diffusion in lymphomatous optic neuropathy. J Neuroophthalmol. 2011;31:306–309.
1. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004;18:1188–1206.